secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bausch Health Companies Inc. (BHC)
CIK:        0000885590
Form:       8-K
Filed at:   2026-01-02T23:59:59+00:00
Accession:  0000950103-26-000052
Event type: debt
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bausch + Lomb closes $2.8B term loan refinancing, reduces margins, extends maturity
--------------------------------------------------------------------------------

- Closed $2.802B Replacement Term Loans maturing 2031 to refinance existing term B loans due 2028 and 2031.
- Interest margin reduced by 0.50% (vs prior 2031 loans) and 0.25% (vs 2028 loans); SOFR+3.75% or ABR+2.75%.
- Amortization at 1.00% per annum, first installment payable June 30, 2026.
- Effective maturity extension of the 2028 loans from September 2028 to January 2031.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885590/000095010326000052/0000950103-26-000052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885590/000095010326000052/dp239511_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950103-26-000052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer